Cargando…

Identification of the Transferrin Receptor as a Novel Immunoglobulin (Ig)a1 Receptor and Its Enhanced Expression on Mesangial Cells in Iga Nephropathy

The biological functions of immunoglobulin (Ig)A antibodies depend primarily on their interaction with cell surface receptors. Four IgA receptors are presently characterized. The FcαRI (CD89) expressed by myeloid cells selectively binds IgA1 and IgA2 antibodies, whereas the poly-IgR, Fcα/μR, and asi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moura, Ivan C., Centelles, Miguel N., Arcos-Fajardo, Michelle, Malheiros, Denise M., Collawn, James F., Cooper, Max D., Monteiro, Renato C.
Formato:	Texto
Lenguaje:	English
Publicado:	The Rockefeller University Press 2001
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2193503/ https://www.ncbi.nlm.nih.gov/pubmed/11514599

Ejemplares similares

Transglutaminase is essential for IgA nephropathy development acting through IgA receptors
por: Berthelot, Laureline, et al.
Publicado: (2012)

Secretory IgA mediates retrotranscytosis of intact gliadin peptides via the transferrin receptor in celiac disease
por: Matysiak-Budnik, Tamara, et al.
Publicado: (2008)

Gut-kidney axis in IgA nephropathy: Role on mesangial cell metabolism and inflammation
por: Luvizotto, Mateus Justi, et al.
Publicado: (2022)

Fcα Receptor (Cd89) Mediates the Development of Immunoglobulin a (Iga) Nephropathy (Berger's Disease): Evidence for Pathogenic Soluble Receptor–Iga Complexes in Patients and Cd89 Transgenic Mice
por: Launay, Pierre, et al.
Publicado: (2000)

Identification of IgA autoantibodies targeting mesangial cells redefines the pathogenesis of IgA nephropathy
por: Nihei, Yoshihito, et al.
Publicado: (2023)

Clinical significance of serum and mesangial galactose-deficient IgA1 in patients with IgA nephropathy
por: Wada, Yukihiro, et al.
Publicado: (2018)

Mesangial cells from patients with IgA nephropathy have increased susceptibility to galactose-deficient IgA1
por: Ebefors, Kerstin, et al.
Publicado: (2016)

Clinical significance of IgG deposition in the glomerular mesangial area in patients with IgA nephropathy
por: Wada, Yukihiro, et al.
Publicado: (2012)

Role of Mononuclear Cells of IgA Nephropathy on ICAM-1 Expression in Mesangial Cells
por: Lee, Tae-Won, et al.
Publicado: (1998)

Erythrocytosis associated with IgA nephropathy
por: Cohen, Camille, et al.
Publicado: (2021)

Tonsillectomy reduces recurrence of IgA nephropathy in mesangial hypercellularity type categorized by the Oxford classification
por: Hirano, Keita, et al.
Publicado: (2015)

RhoA vesicle trafficking–mediated transglutaminase 2 membrane translocation promotes IgA1 mesangial deposition in IgA nephropathy
por: Zhong, Zhong, et al.
Publicado: (2023)

Is There a Role for Gut Microbiome Dysbiosis in IgA Nephropathy?
por: Monteiro, Renato C., et al.
Publicado: (2022)

Targeting the Endothelin A Receptor in IgA Nephropathy
por: Kohan, Donald E., et al.
Publicado: (2023)

Role of Polymeric Immunoglobulin Receptor in IgA and IgM Transcytosis
por: Wei, Hao, et al.
Publicado: (2021)

Toll-Like Receptor 4 Signaling is Involved in IgA-Stimulated Mesangial Cell Activation
por: Lim, Beom Jin, et al.
Publicado: (2011)

Volatile Organic Metabolites Identify Patients with Mesangial Proliferative Glomerulonephritis, IgA Nephropathy and Normal Controls
por: Wang, Changsong, et al.
Publicado: (2015)

Clinicopathologic and Prognostic Study of Primary IgA Nephropathy With Light Chain λ Restriction in the Mesangial Deposits
por: Zhang, Ji, et al.
Publicado: (2022)

Distribution pattern of mesangial C4d deposits as predictor of kidney failure in IgA nephropathy
por: Worawichawong, Suchin, et al.
Publicado: (2021)

CCL20 secreted from IgA1-stimulated human mesangial cells recruits inflammatory Th17 cells in IgA nephropathy
por: Lu, Guoyuan, et al.
Publicado: (2017)

IgA1 dominant subclass of latent IgA mesangial deposition in donated kidney
por: Oka, Kazumasa, et al.
Publicado: (2016)

Sialylation of IgG inhibits the formation of galactose-deficient IgA1-containing immune complexes and protects mesangial cells from injury in IgA nephropathy
por: Liu, Youxia, et al.
Publicado: (2022)

Urokinase-type plasminogen activator receptor in IgA nephropathy
por: Ahn, Shin-Young, et al.
Publicado: (2014)

Acteoside relieves mesangial cell injury by regulating Th22 cell chemotaxis and proliferation in IgA nephropathy
por: Gan, Lu, et al.
Publicado: (2018)

Factors associated with the progression of mesangial lesions in IgA nephropathy: A comparative analysis of renal re-biopsies
por: Li, Yetong, et al.
Publicado: (2022)

Rare Collagenous Heterozygote Variants in Children With IgA Nephropathy
por: Cambier, Alexandra, et al.
Publicado: (2021)

Combined blockade of angiotensin II and prorenin receptors ameliorates podocytic apoptosis induced by IgA-activated mesangial cells
por: Leung, Joseph C. K., et al.
Publicado: (2015)

The Role of IgA in the Pathogenesis of IgA Nephropathy
por: Perše, Martina, et al.
Publicado: (2019)

An IgA mimicry of IgG that binds polymeric immunoglobulin receptor for mucosa transcytosis
por: Mao, Changchuin, et al.
Publicado: (2020)

Tumor Necrosis Factor α from Peripheral Blood Mononuclear Cells of IgA Nephropathy and Mesangial Cell Proliferation
por: Lee, Tae-Won, et al.
Publicado: (1994)

SUMO1 Promotes Mesangial Cell Proliferation Through Inhibiting Autophagy in a Cell Model of IgA Nephropathy
por: Tan, Xia, et al.
Publicado: (2022)

IgA Vasculitis and IgA Nephropathy: Same Disease?
por: Pillebout, Evangeline
Publicado: (2021)

Dimeric and polymeric IgA, but not monomeric IgA, enhance the production of IL-6 by human renal mesangial cells
por: Reterink, T. J. F., et al.
Publicado: (1996)

Tetrandrine inhibits the proliferation of mesangial cells induced by enzymatically deglycosylated human IgA1 via IgA receptor/MAPK/NF-κB signaling pathway
por: Xu, Wencheng, et al.
Publicado: (2023)

Experimental IgA nephropathy
Publicado: (1979)

Sulodexide in IgA nephropathy
Publicado: (2013)

T lymphocytes in IgA nephropathy
por: Tang, Yuyan, et al.
Publicado: (2020)

Current treatment of IgA nephropathy
por: Floege, Jürgen, et al.
Publicado: (2021)

Decreased Circulating C3 Levels and Mesangial C3 Deposition Predict Renal Outcome in Patients with IgA Nephropathy
por: Kim, Seung Jun, et al.
Publicado: (2012)

Synergistic Effect of Mesangial Cell-Induced CXCL1 and TGF-β1 in Promoting Podocyte Loss in IgA Nephropathy
por: Zhu, Li, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_s18njsjase737t3lgk8a1snq62